Hoffmann-La Roche: Down Syndrome trials
The registry lists 10 Down Syndrome studies with Hoffmann-La Roche as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 2No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of AgeTerminatedNCT02484703Phase 2
- Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down SyndromeCompletedNCT02451657
- Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30CompletedNCT02431117
- A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)CompletedNCT02024789Phase 2
- A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)CompletedNCT01920633
- A Molecular and Functional Brain Imaging Study in Individuals With Down Syndrome and Healthy Controls Following Single Dose RG1662CompletedNCT01667367Phase 1
- A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down SyndromeCompletedNCT01580384
- Non-invasive Chromosomal Examination of Trisomy StudyCompletedNCT01511458
- A Study of RG1662 in Individuals With Down SyndromeCompletedNCT01436955Phase 1
- Prenatal Test for Fetal Aneuploidy DetectionCompletedNCT01256606